VCCBH News


Celebrating Larner’s Newest Facility: The Firestone Medical Research Building

October 28, 2022 by Jennifer Nachbur

On October 27, 2022, the UVM Larner College of Medicine held a grand opening and dedication of the newest addition to the medical campus: the Firestone Medical Research Building.

(R-L) Casey; Firestone; Page; Garimella; Prelock; Keith Robinson; Sarah Lindenfeld; Gordon Jensen, M.D., Ph.D.; Rick Morin, M.D.; H. David Reines, M.D.'72; Matt Cooke; Malone. (Photo: David Seaver)

It was a typical late fall day in Vermont – a mix of gray skies and sun with a cool wind blowing – but the tone was bright and celebratory at the October 27 grand opening and dedication of the newest addition to the Larner College of Medicine’s campus: the Firestone Medical Research Building. In attendance at the dedication ceremony were donors, leaders from across the College of Medicine, University of Vermont and UVM Health Network, medical alumni, faculty, staff, students and research trainees, and community and business leaders. Also present were representatives of architects Payette Associates and Black River Design and the main contractor for the building, Vermont-based PC Construction.

The event marked the conclusion of a two-year-and-twenty-nine-day journey, which started during the first year of the COVID-19 pandemic, when many construction projects across the state had halted.

Despite the stay-at-home order in place in September 2020, biomedical research on the SARS-CoV2 virus at the University of Vermont’s medical school was operating in high gear.

“Those early days of the pandemic taught us many lessons, some of them heartbreaking in nature, and they deeply underscored the value of biomedical research,” said Larner College of Medicine Dean Richard L. Page, M.D., during his welcome remarks at the event. “So even in the depths of the crisis, when we might have been forgiven, and forgiven ourselves, for delaying the plans for the Firestone Building until less tumultuous times, we decided to forge ahead,” Page added.

The seeds of inspiration for the building were planted by its lead donor, Larner alum and retired anesthesiologist Steve Firestone, M.D.’69, who several years ago began exploring where to focus a gift in memory of his mother and his father, Dr. Frederick Firestone. The senior Dr. Firestone had received medical training in Vienna, Austria in the 1930s, made his way to the United States, completed his medical internship, and joined the U.S. Army during the Second World War, where he served in Europe as a battalion surgeon and earned two Silver Star Medals. After the war, he opened a modest medical practice, where his wife, Bobbie, worked alongside him as a nurse, and they served their community for many years.

The new building represents the university’s and college’s commitment to research excellence, student success, patient care, and community service. UVM President Suresh Garimella underscored how advanced research technology housed in the new Firestone Building provides an example of this commitment.

“The work that happens on this campus every day—in every college and school—directly impacts the quality of life for people near and far,” said Garimella. “The Center for Shared Biomedical Resources is a key example of our institution bringing into being a resource for the entire region, beyond just those directly connected to UVM. Researchers at other institutions and in state government will be able to take advantage of the technology at the center.”

Providing an environment for both deliberate investigation and serendipitous innovation were intentional components of the building’s design, and an aspect highly valued by Mary Cushman, M.D., M.Sc., and Mark Nelson, Ph.D., who are co-directors of the Vermont Center on Cardiovascular and Brain Health (VCCBH), which will be located on Firestone’s fourth floor.

“This building will focus on collaboratively advancing research that supports healthy life and builds and sustain vibrant economies and communities,” said Cushman, who referenced the adjacent location of state-of-the-art laboratories and a “collaboratory” for idea sharing in the VCCBH’s space.

Marilyn Cipolla, Ph.D., professor of neurological sciences, chair of electrical and biomedical engineering, and a UVM B.S., M.S., and Ph.D. degree alum, said during her remarks, "I can't think of a better way to amplify our impact here at UVM than training the next generation.”

Symbolically, graduate students Kiera Malone and Dylan Casey, who will be training and working in the Firestone Building, held each end of the ribbon that was cut at the close of the October 27 event to formally open the facility. Malone, a Cellular, Molecular and Biomedical Sciences doctoral student, works on cancer-related research with Karen Glass, Ph.D., associate professor of pharmacology. A type 1 diabetic, Malone understands the importance of biomedical research from the perspective of both a patient and a scientist.

“I really hope that we can make change for everybody, and those, especially, who need it the most,” she said during an interview with local television news station NBC5.



Recent Stories and Publications Featuring VCCBH Members


Target ALS LinkedIn Post Featuring Research by Dr. Kathryn H. Morelli, PhD

Posted January 4, 2025

"ALS is a devastating disease, but researchers like Kathryn H. Morelli, Ph.D., a Target ALS Springboard Fellow and now an assistant professor at the University of Vermont, are driving innovations that bring us closer to effective treatments. Focused on developing RNA-targeted therapies for C9orf72 ALS, one of the most common genetic causes of the disease, Kathy’s work showcases the critical importance of collaboration, cutting-edge tools, and determination..."

Advancing ALS Research with Stem Cell Resources and Targeted Reagents: The Role of Target ALS in the Quest for Effective Treatment

Posted January 4, 2025

"ALS is a devastating neurodegenerative disease, and while there is no cure, ongoing research continues to offer hope for more effective treatments. An individual at the forefront of these efforts is Dr. Kathryn Morelli, an assistant professor in the Department of Neurological Sciences at the University of Vermont’s Larner College of Medicine, whose research aims to address the complex challenges of ALS, building on work she did with her postdoctoral mentor Dr. Gene Yeo. Working closely with Abby Kirch, a PhD student in her lab, Kathy and her team are focused on developing RNA-targeted therapies for ALS, particularly for the C9ORF72 mutation, one of the most common genetic causes of the disease..."

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted December 4, 2024

"On November 16, Larner Assistant Professor of Medicine Debora Kamin Mukaz, Ph.D., M.S., moderated a panel on science policy advocacy titled “How can we engage scientists from historically underrepresented backgrounds in policymaking and advocacy?” at the American Heart Association’s Scientific Sessions 2024 conference in Chicago. The panelists were AHA President Keith Churchwell, M.D.; past AHA President Michelle Albert, M.D., M.P.H.; Emelia Benjamin, M.D., Sc.M., associate provost and professor of medicine and epidemiology at Boston University; and Carl Streed, Jr., M.D., M.P.H., associate professor of medicine at Boston University..."

Research on spider brain leads to groundbreaking Alzheimer’s discovery

Posted December 3, 2024

"Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains 
Vermont Business Magazine Researchers from Saint Michael’s College and the University of Vermont have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain..."

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

"In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity..."

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

"Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration..."

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

"The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood..."

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

"Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it..."